SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-004010
Filing Date
2020-02-14
Accepted
2020-02-14 17:15:52
Documents
3
Period of Report
2020-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k021320_aytubioscience.htm 8-K 39919
2 CONSENT OF HALL & COMPANY RELATING TO INNOVUS' FINANCIAL STATEMENTS f8k021320ex23-1_aytubio.htm EX-23.1 2041
3 UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF JUNE 30, 2019 AND STA f8k021320ex99-3_aytubio.htm EX-99.3 561651
  Complete submission text file 0001213900-20-004010.txt   605064
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 20621918
SIC: 2834 Pharmaceutical Preparations